• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 10-K/A filed by Gevo Inc.

    8/15/25 4:05:30 PM ET
    $GEVO
    Major Chemicals
    Industrials
    Get the next $GEVO alert in real time by email
    GEVO, INC._December 31, 2024
    0001392380FYtrueP1YP1YP1YP1YP1YP1YP1YP1YP1YP1YP1YP1YP1YP1YGevo, Inc. (the "Company") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment") to its Annual Report on Form 10-K for the year ended December 31, 2024, which was originally filed with the Securities and Exchange Commission (the "SEC") on March 27, 2025 (the "Original Filing"). This Amendment is being filed solely to amend Part II "Item 9B. Other Information" by adding Rule 10b5-1 trading arrangements entered into by each of Angelo Amorelli and Gary W. Mize, directors of the Company, during the three months ended December 31, 2024, which were inadvertently omitted from the disclosure included in the Original Filing. In addition, as required by Rule 12b-15 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), new certifications by the Company's principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment, under Item 15 hereof, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. The Company is also not including new certifications under Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) (Section 906 of the Sarbanes-Oxley Act of 2002), as no financial statements are being filed with this Amendment. Other than as expressly set forth herein, this Amendment does not, and does not purport to, amend, update or restate the information in the Original Filing or reflect any events that have occurred after the Original Filing was made. Information in the Original Filing not affected by this Amendment remains unchanged and reflects the disclosures made at the time as of which the Original Filing was made. No changes have been made to the financial statements of the Company as contained in the Original Filing. Accordingly, this Amendment should be read together with the Original Filing and the Company's other filings with the SEC.0001392380gevo:PaulD.BloomMembergevo:PlanJuly262024ToJuly252025Member2024-12-310001392380gevo:PaulD.BloomMembergevo:PlanFebruary202025ToFebruary192026Member2024-12-310001392380gevo:PatrickR.GruberMembergevo:PlanJuly262024ToJuly252025Member2024-12-310001392380gevo:PatrickR.GruberMembergevo:PlanFebruary172025ToFebruary162026Member2024-12-310001392380gevo:L.LynnSmullMembergevo:PlanJuly262024ToJuly252025Member2024-12-310001392380gevo:L.LynnSmullMembergevo:PlanFebruary262025ToFebruary252026Member2024-12-310001392380gevo:KimberlyT.BowronMembergevo:PlanMarch32025ToMarch42026Member2024-12-310001392380gevo:KimberlyT.BowronMembergevo:PlanJuly262024ToJuly252025Member2024-12-310001392380gevo:GaryW.MizeMembergevo:PlanMay232025ToMay222026Member2024-12-310001392380gevo:ChristopherM.RyanMembergevo:PlanJuly262024ToJuly252025Member2024-12-310001392380gevo:ChristopherM.RyanMembergevo:PlanFebruary262025ToFebruary252026Member2024-12-310001392380gevo:AngeloAmorelliMembergevo:PlanMarch72025ToMarch62026Member2024-12-310001392380gevo:AndrewL.ShaferMembergevo:PlanNovember12024ToOctober312025Member2024-12-310001392380gevo:AndrewL.ShaferMembergevo:PlanFebruary202025ToFebruary192026Member2024-12-310001392380gevo:PaulD.BloomMembergevo:PlanJuly262024ToJuly252025Member2024-10-012024-12-310001392380gevo:PatrickR.GruberMembergevo:PlanJuly262024ToJuly252025Member2024-10-012024-12-310001392380gevo:L.LynnSmullMembergevo:PlanJuly262024ToJuly252025Member2024-10-012024-12-310001392380gevo:KimberlyT.BowronMembergevo:PlanJuly262024ToJuly252025Member2024-10-012024-12-310001392380gevo:ChristopherM.RyanMembergevo:PlanJuly262024ToJuly252025Member2024-10-012024-12-310001392380gevo:AndrewL.ShaferMembergevo:PlanNovember12024ToOctober312025Member2024-10-012024-12-310001392380gevo:PaulD.BloomMembergevo:PlanFebruary202025ToFebruary192026Member2024-10-012024-12-310001392380gevo:PatrickR.GruberMembergevo:PlanFebruary172025ToFebruary162026Member2024-10-012024-12-310001392380gevo:L.LynnSmullMembergevo:PlanFebruary262025ToFebruary252026Member2024-10-012024-12-310001392380gevo:KimberlyT.BowronMembergevo:PlanMarch32025ToMarch42026Member2024-10-012024-12-310001392380gevo:GaryW.MizeMembergevo:PlanMay232025ToMay222026Member2024-10-012024-12-310001392380gevo:ChristopherM.RyanMembergevo:PlanFebruary262025ToFebruary252026Member2024-10-012024-12-310001392380gevo:AngeloAmorelliMembergevo:PlanMarch72025ToMarch62026Member2024-10-012024-12-310001392380gevo:AndrewL.ShaferMembergevo:PlanFebruary202025ToFebruary192026Member2024-10-012024-12-3100013923802024-10-012024-12-3100013923802024-06-3000013923802025-01-3100013923802024-01-012024-12-31xbrli:sharesiso4217:USD

    ​

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 10-K/A

    (Amendment No. 1)

    ​

    ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    ​

    For the fiscal year ended December 31, 2024

    ​

    OR

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    ​

    For the transition period from                      to                     

    ​

    Commission file number: 001-35073

    ​

    GEVO, INC.

    (Exact name of registrant as specified in its charter)

    ​

    ​

    ​

    Delaware

    87-0747704

    (State or other jurisdiction of

    incorporation or organization)

    (I.R.S. Employer

    Identification No.)

    ​

    ​

    345 Inverness Drive South,

    Building C, Suite 310

    Englewood, CO

    80112

    (Address of principal executive offices)

    (Zip Code)

    ​

    (303) 858-8358

    (Registrant’s telephone number, including area code)

    ​

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    ​

    ​

    ​

    ​

    ​

    Title of Each Class

        

    Trading Symbol

        

    Name of Each Exchange on Which Registered

    Common Stock, par value $0.01 per share

    ​

    GEVO

    ​

    The Nasdaq Stock Market LLC

    ​

    Securities registered pursuant to Section 12(g) of the Act:

    None

    ​

    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

    ​

    Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

    ​

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

    ​

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

    ​

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

    ​

    ​

    ​

    ​

    ​

    Large accelerated filer

    ☐

    Accelerated filer

    ☐

    Non-accelerated filer

    ☒

    Smaller reporting company

    ☒

    ​

    ​

    Emerging growth company

    ☐

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

    ​

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

    ​

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

    ​

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

    ​

    The aggregate market value of common equity held by non-affiliates of the registrant was approximately $0.4 billion as of June 30, 2024, the last trading day of the registrant’s most recently completed second fiscal quarter, based on the closing price of the common stock as reported on the Nasdaq Capital Market on June 30, 2024. Shares of common stock held by each officer, director and holder of 10% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

    ​

    As of January 31, 2025, the number of outstanding shares of the registrant’s common stock, par value $0.01 per share, was 240,499,833.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    EXPLANATORY NOTE

    Gevo, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the year ended December 31, 2024, which was originally filed with the Securities and Exchange Commission (the “SEC”) on March 27, 2025 (the “Original Filing”). This Amendment is being filed solely to amend Part II “Item 9B. Other Information” by adding Rule 10b5-1 trading arrangements entered into by each of Angelo Amorelli and Gary W. Mize, directors of the Company, during the three months ended December 31, 2024, which were inadvertently omitted from the disclosure included in the Original Filing.

    In addition, as required by Rule 12b-15 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by the Company’s principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment, under Item 15 hereof, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. The Company is also not including new certifications under Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) (Section 906 of the Sarbanes-Oxley Act of 2002), as no financial statements are being filed with this Amendment.

    Other than as expressly set forth herein, this Amendment does not, and does not purport to, amend, update or restate the information in the Original Filing or reflect any events that have occurred after the Original Filing was made. Information in the Original Filing not affected by this Amendment remains unchanged and reflects the disclosures made at the time as of which the Original Filing was made. No changes have been made to the financial statements of the Company as contained in the Original Filing. Accordingly, this Amendment should be read together with the Original Filing and the Company’s other filings with the SEC.

    ​

    ​

    ​

    Item 9B.Other Information

    During the three months ended December 31, 2024, the below directors and/or officers, as defined in Rule 16a-1(f), adopted, modified or terminated a “Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K. The Rule 10b5-1 trading arrangements were each intended to satisfy the affirmative defense in Rule 10b5-1(c)(1).

    ​

    ​

    ​

    ​

    ​

    Name and Title

    Action

    Date

    Duration of Plan

    Total Number of Shares
    of Common Stock to be
    Purchased or Sold

    Patrick R. Gruber

    Chief Executive Officer

    Terminate

    November 14, 2024

    July 26, 2024 to July 25, 2025

    Up to 815,015

    Patrick R. Gruber

    Chief Executive Officer

    Adopt

    November 14, 2024

    February 17, 2025 to February 16, 2026

    Up to 2,957,838

    Christopher M. Ryan

    President and Chief Operating Officer

    Terminate

    November 26, 2024

    July 26, 2024 to July 25, 2025

    Up to 341,227

    Christopher M. Ryan

    President and Chief Operating Officer

    Adopt

    November 26, 2024

    February 26, 2025 to February 25, 2026

    Up to 853,643

    L. Lynn Smull

    Chief Financial Officer

    Terminate

    November 25, 2024

    July 26, 2024 to July 25, 2025

    Up to 166,264

    L. Lynn Smull

    Chief Financial Officer

    Adopt

    November 25, 2024

    February 26, 2025 to February 25, 2026

    Up to 115,647

    Paul D. Bloom

    Chief Business Officer

    Terminate

    November 21, 2024

    July 26, 2024 to July 25, 2025

    Up to 308,814

    Paul D. Bloom

    Chief Business Officer

    Adopt

    November 21, 2024

    February 20, 2025 to February 19, 2026

    Up to 718,587

    Andrew L. Shafer

    Chief Customer, Marketing and Brand Officer

    Terminate

    November 22, 2024

    November 1, 2024 to October 31, 2025

    Up to 60,606

    Andrew L. Shafer

    Chief Customer, Marketing and Brand Officer

    Adopt

    November 22, 2024

    February 20, 2025 to February 19, 2026

    Up to 146,242

    Kimberly T. Bowron

    Chief People and IT Officer

    Terminate

    December 2, 2024

    July 26, 2024 to July 25, 2025

    Up to 88,960

    Kimberly T. Bowron

    Chief People and IT Officer

    Adopt

    December 2, 2024

    March 3, 2025 to March 4, 2026

    Up to 136,960

    Angelo Amorelli

    Director

    Adopt

    December 6, 2024

    March 7, 2025 to March 6, 2026

    Up to 324,639

    Gary W. Mize

    Director

    Adopt

    December 3, 2024

    May 23, 2025 to May 22, 2026

    Up to 224,639

    ​

    Except as set forth above, no director or officer, as defined in Rule 16a-1(f), adopted, modified and/or terminated a “Rule 10b5-1 trading arrangement,” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K, during the three months ended December 31, 2024.

    ​

    ​

    PART IV

    Item 15.

    Exhibits, Financial Statement Schedules

    The following exhibits are filed as part of this Amendment:

    Exhibit
    No.

        

    Description

    ​

    ​

    ​

    ​

    ​

    ​

    31.1*

    ​

    Section 302 Certification of the Principal Executive Officer.

    ​

    ​

    ​

    31.2*

    ​

    Section 302 Certification of the Principal Financial Officer.

    ​

    ​

    ​

    101.INS

    ​

    Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

    ​

    ​

    ​

    101.SCH

    ​

    Inline XBRL Taxonomy Extension Schema

    ​

    ​

    ​

    101.CAL

    ​

    Inline XBRL Taxonomy Extension Calculation Linkbase

    ​

    ​

    ​

    101.DEF

    ​

    Inline XBRL Taxonomy Extension Definition Linkbase

    ​

    ​

    ​

    01.LAB

    ​

    Inline XBRL Taxonomy Extension Label Linkbase

    ​

    ​

    ​

    101.PRE

    ​

    Inline XBRL Taxonomy Extension Presentation Linkbase

    ​

    ​

    ​

    104

    ​

    Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

    *Filed Herewith

    ​

    ​

    ​

    SIGNATURES

    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

    ​

    ​

    ​

    ​

    Gevo, Inc.

    ​

    (REGISTRANT)

    ​

    ​

    ​

    By:

    /s/ Sylvia Gendenjamts

    ​

    ​

    Sylvia Gendenjamts, CPA
    Vice President Accounting and Treasurer
    (Principal Accounting Officer)

    ​

    ​

    ​

    Date: August 15, 2025

    ​

    ​

    ​

    ​

    Get the next $GEVO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEVO

    DatePrice TargetRatingAnalyst
    8/21/2023$2.00Market Perform
    Northland Capital
    12/14/2022$2.25Neutral
    UBS
    10/19/2022$2.29Hold
    Jefferies
    2/9/2022$5.00Buy
    Citigroup
    8/24/2021$10.00Buy
    Stifel
    More analyst ratings

    $GEVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Amorelli Angelo exercised 100,000 shares at a strike of $0.67 and sold $390,531 worth of shares (200,000 units at $1.95), decreasing direct ownership by 97% to 2,942 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    8/15/25 4:30:08 PM ET
    $GEVO
    Major Chemicals
    Industrials

    CFO Agiri Oluwagbemileke Yusuf sold $7,061 worth of shares (5,738 units at $1.23), decreasing direct ownership by 2% to 335,486 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    8/6/25 4:57:46 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Chief Advocacy & Comms Officer Fitzgerald Lindsay Clinton sold $9,990 worth of shares (8,118 units at $1.23), decreasing direct ownership by 3% to 232,199 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    8/6/25 4:56:45 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    SEC Filings

    View All

    SEC Form 144 filed by Gevo Inc.

    144 - Gevo, Inc. (0001392380) (Subject)

    8/18/25 4:29:29 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form 10-K/A filed by Gevo Inc.

    10-K/A - Gevo, Inc. (0001392380) (Filer)

    8/15/25 4:05:30 PM ET
    $GEVO
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Gevo Inc.

    10-Q - Gevo, Inc. (0001392380) (Filer)

    8/11/25 4:36:20 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Gevo with a new price target

    Northland Capital initiated coverage of Gevo with a rating of Market Perform and set a new price target of $2.00

    8/21/23 9:21:52 AM ET
    $GEVO
    Major Chemicals
    Industrials

    UBS initiated coverage on Gevo with a new price target

    UBS initiated coverage of Gevo with a rating of Neutral and set a new price target of $2.25

    12/14/22 7:48:29 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Jefferies initiated coverage on Gevo with a new price target

    Jefferies initiated coverage of Gevo with a rating of Hold and set a new price target of $2.30

    10/19/22 8:39:11 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gevo Reports Second Quarter 2025 Financial Results

    Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025  Positive Net Income Attributable to Gevo of $2.1 million in the Second QuarterPositive Adjusted EBITDA1 of $17 million in the Second QuarterRevenues Increased $14 million Quarter-Over-QuarterPositive Earnings per Share Attributable to Gevo of $0.01 for the Second QuarterResults Driven by Successful Execution on Low-Carbon Ethanol and Carbon Capture Acquisition, First Sales of Clean Fuel Production Credits ENGLEWOOD, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading develo

    8/11/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo to Report Second Quarter 2025 Financial Results on August 11, 2025

    ENGLEWOOD, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on August 11, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the second quarter that ended June 30, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI837becc646fa4780899cbd8ed1b21b9a After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/u9fuak7q A webcast replay will be available two

    7/24/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Sells Carbon Credits from North Dakota Asset

    ENGLEWOOD, Colo., July 21, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that it is selling carbon abatement into the market for the first time. To support decarbonization and to mitigate its corporate travel emissions, the buyer, a global financial and technology company, purchased high-integrity durable carbon removal credits, known as CORCs (or CO2 Removal Certificates), that are Puro.earth-certified and are ready to retire immediately. CORCs provide true carbon abatement, with a volume of actual carbon dioxide permanently removed from circulation, which offsets the effect of emissions. Selling high-integrity CORCs is core to Gevo's strategy, with the rapid

    7/21/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Leadership Updates

    Live Leadership Updates

    View All

    Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

    ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

    5/27/25 4:10:00 PM ET
    $GEVO
    $GHM
    Major Chemicals
    Industrials
    Industrial Machinery/Components

    Gevo Promotes Leke Agiri to Chief Financial Officer

    ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), is pleased to announce the appointment of Oluwagbemileke (Leke) Agiri as Chief Financial Officer, effective as of May 21, 2025. Mr. Agiri succeeds L. Lynn Smull, who will continue with the Company in a new role as Executive Vice President and Senior Advisor to the Chief Executive Officer, focusing on strategic initiatives and to aide and support a seamless transition. Mr. Agiri brings extensive experience and leadership in corporate finance, capital markets, and strategic growth, both organic and inorganic. Since joining Gevo in August 2022, he has served in key leadership roles, most recently as Executive Vice P

    5/27/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Announces Appointment of Katie Ellet to Board of Directors

    ENGLEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Katie Ellet has been appointed to its board of directors as of January 2, 2024. Ms. Ellet serves as president, Hydrogen Energy and Mobility for North America at Air Liquide, a world leader in gases, technologies and services for Industry and Health, and a global innovator in low carbon hydrogen production. She has held a wide variety of leadership roles in the chemical and energy fields for the last 27 years. "We are honored to have Katie join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "She has a demonstrated record of technology expertise, market knowledge, and inn

    1/3/24 4:05:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Financials

    Live finance-specific insights

    View All

    Gevo Reports Second Quarter 2025 Financial Results

    Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025  Positive Net Income Attributable to Gevo of $2.1 million in the Second QuarterPositive Adjusted EBITDA1 of $17 million in the Second QuarterRevenues Increased $14 million Quarter-Over-QuarterPositive Earnings per Share Attributable to Gevo of $0.01 for the Second QuarterResults Driven by Successful Execution on Low-Carbon Ethanol and Carbon Capture Acquisition, First Sales of Clean Fuel Production Credits ENGLEWOOD, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading develo

    8/11/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo to Report Second Quarter 2025 Financial Results on August 11, 2025

    ENGLEWOOD, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on August 11, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the second quarter that ended June 30, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI837becc646fa4780899cbd8ed1b21b9a After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/u9fuak7q A webcast replay will be available two

    7/24/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Reports First Quarter 2025 Financial Results

    Quarterly Revenue Increased $25 Million Compared to First Quarter of 2024 Due to Strategic Growth Initiatives  Further Revenue and Adjusted EBITDA1 Growth is Expected in 2025  Gevo to Host Conference Call Today at 4:30 p.m. ET ENGLEWOOD, Colo., May 13, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals that also can deliver significant carbon emission abatement, today announced financial results for the first quarter ended March 31, 2025. Recent Corporate Highlights: Continuing on a Path to Positive Adjusted EBITDA1  Revenue and Adjusted EBITDA growth: Total op

    5/13/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    11/12/24 4:02:11 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    11/4/24 11:58:10 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    7/8/24 4:32:39 PM ET
    $GEVO
    Major Chemicals
    Industrials